Ticlopidine induced cholestatic jaundice

Singapore Medical Journal

Volumn 38, Issue 3, 1997, Pages 132-133

  Yim, H B ^a   Lieu, P K ^a   Choo, P W J ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Adverse side effects; Cholestatic jaundice ticlopidine

Indexed keywords

ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

AGED; ARTICLE; BLOOD DYSCRASIA; CASE REPORT; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; LIVER FUNCTION; OBSTRUCTIVE JAUNDICE; STROKE; VASCULAR DISEASE;

AGED; CEREBROVASCULAR DISORDERS; CHOLESTASIS; FATAL OUTCOME; FEMALE; HUMANS; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0030986547     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Gent M, Blakeley JA, Easton JD, et al.The Canadian American Tidopidine Study (CATS) in thromboembolic stroke. Lancet 1989; 1:1215-20.
2. Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321:501-7.
3. Janzon L, Bergqvist D, Boberg J, et al. Prevention of myocardial infarction and stroke in patients with intermittent claudication, effects of ticlopidine. Results from STIMS, the Swedish Tidopidine Multicentre Study, J Intern Med 1990; 227:301-8.
4. Yoder JD, Gary JA, Geoffrey WH. More ticlopidine-induced cholestatic jaundice, Am J Hosp Pharm 1994; 51:1821-2.
5. Grimm IS, Litynski JJ. Severe cholestasis associated with ticlopidine Am J Geriatr 1994; 89(2):279-80.
6. Greaney JJ, Hess DA, Mahoney CD. Severe cholestasis associated with ticlopidine. Clin Pharm 1993; 12:398-9.
7. Sondaq D, Bader R, Claude P, et al. Hepatite a la ticlopidine: un nouveau cas. Ann Gastroenterol Hepatol 1993; 29:40-1.